Results 21 to 30 of about 725,225 (258)

Bordetella hinzii Meningitis in Patient with History of Kidney Transplant, Virginia, USA

Emerging Infectious Diseases, 2021
A patient in Virginia, USA, who had previously undergone multiple kidney transplantations showed signs of Bordetella hinzii bacteremia and meningitis.
Joseph Pechacek, Jillian Raybould, Megan Morales   +2 more
doaj   +1 more source

Umbilical cord blood transplantation: Still growing and improving

Stem Cells Translational Medicine, 2021
Umbilical cord blood transplantation (UCBT) has been performed in the clinic for over 30 years. The biological and immunological characteristics of umbilical cord blood (UCB) have been re‐recognized in recent years.
Xiaoyu Zhu, Baolin Tang, Zimin Sun
doaj   +1 more source

Mesenchymal Stromal Cells for Transplant Tolerance

Frontiers in Immunology, 2019
In solid organ transplantation lifelong immunosuppression exposes transplant recipients to life-threatening complications, such as infections and malignancies, and to severe side effects. Cellular therapy with mesenchymal stromal cells (MSC) has recently
Manuel Alfredo Podestà, Manuel Alfredo Podestà, Giuseppe Remuzzi, Federica Casiraghi   +3 more
doaj   +1 more source

Potential Roles of Long Noncoding RNAs as Therapeutic Targets in Organ Transplantation

Frontiers in Immunology, 2022
Organ transplantation is the most preferred treatment option for end-stage organ diseases; however, allograft rejection is the major hurdle in successful long-term transplant survival.
Saeedeh Salehi, Shima Afzali, Abbas Shahi, Abbas Shahi, Ali Akbar Amirzargar, Yaser Mansoori   +5 more
doaj   +1 more source

Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation

Frontiers in Immunology, 2023
The critical balance between intended and adverse effects in allogeneic hematopoietic stem cell transplantation (alloHSCT) depends on the fate of individual donor T-cells.
Benedikt Obermayer, Luisa Keilholz, Luisa Keilholz, Thomas Conrad, Thomas Conrad, Marco Frentsch, Marco Frentsch, Igor-Wolfgang Blau, Lam Vuong, Lam Vuong, Stella Lesch, Stella Lesch, Kamran Movasshagi, Kamran Movasshagi, Carola Tietze-Stolley, Carola Tietze-Stolley, Lucie Loyal, Lucie Loyal, Lucie Loyal, Larissa Henze, Larissa Henze, Larissa Henze, Olaf Penack, Olaf Penack, Ulrik Stervbo, Ulrik Stervbo, Nina Babel, Nina Babel, Simon Haas, Simon Haas, Simon Haas, Dieter Beule, Lars Bullinger, Lars Bullinger, Lars Bullinger, Friedrich Wittenbecher, Friedrich Wittenbecher, Il-Kang Na, Il-Kang Na, Il-Kang Na, Il-Kang Na, Il-Kang Na   +41 more
doaj   +1 more source

Are Fertility Preservation Procedures Before Gonadotoxic Therapy and Hematopoietic Stem Cell Transplantation Feasible and Safe in Very Young Children? A Retrospective Cohort Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Fertility preservation (FP) is increasingly integrated into the care of pediatric patients exposed to gonadotoxic therapy or conditioning for hematopoietic stem cell transplantation (HSCT), yet perioperative data in infants and toddlers remain scarce.
Kerstin Saalabian, Yannick Braun, Till‐Martin Theilen, Anke Barnbrock, Theresa Rohm, Fabienne Hammant, Nicole Sänger, Aynura Abbasova‐Semiz, Jan‐Henning Klusmann, Thomas Klingebiel, Udo Rolle, Peter Bader, Henning C. Fiegel, Andrea Jarisch   +13 more
wiley   +1 more source

Inhibition of complement activation by CD55 overexpression in human induced pluripotent stem cell derived kidney organoids

Frontiers in Immunology, 2023
End stage renal disease is an increasing problem worldwide driven by aging of the population and increased prevalence of metabolic disorders and cardiovascular disease.
Lonneke H. Gaykema, Lonneke H. Gaykema, Rianne Y. van Nieuwland, Mette C. Dekkers, Mieke F. van Essen, Sebastiaan Heidt, Sebastiaan Heidt, Arnaud Zaldumbide, Cathelijne W. van den Berg, Cathelijne W. van den Berg, Ton J. Rabelink, Ton J. Rabelink, Cees van Kooten   +12 more
doaj   +1 more source

Prevalence of 21 Physician‐Defined Severe Toxicities Following Childhood Acute Lymphoblastic Leukemia Treatment: Australian Retrospective Cohort Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with an overall survival now surpassing 90% in developed countries. However, treatments are not without adverse effects. In this study, we apply the severe toxicity‐free survival (STFS) framework to determine the prevalence of 21 physician‐defined severe ...
Lane Collier, Brittany Grantham, Camilla Grud Nielsen, Louise Lundgren, Liv Andrés‐Jensen, Kjeld Schmiegelow, Chris Selman, Gareth Ball, Elyse Passmore, David A. Elliott, Rachel Conyers   +10 more
wiley   +1 more source

Blood and blood products to support allogeneic hematopoietic progenitor cell transplant recipients at king abdulaziz medical city-Riyadh – Transfusion medicine services

Journal of Applied Hematology, 2022
Hematopoietic progenitor cell transplant (HPCT) is found throughout the body. HPCT is a set of undifferentiated cells that are capable of indefinite self-renewal and generation of a functional progeny of highly specialized cells. Allogeneic HPCT presents
Ahmed Al Harbi, Abdullah Al-Anazi, Faisal Al Saqri, Haya Wasel   +3 more
doaj   +1 more source

Improved Early Referral in Long‐Term Survivor Care With Institutional Standardized Practice Among Childhood Leukemia Survivors#

Pediatric Blood &Cancer, EarlyView.
ABSTRACT In 2018, the Texas Children's Cancer and Hematology Center Leukemia Program implemented a practice standard to support the transition from treatment to survivorship that includes shared, alternating care between leukemia and survivorship clinicians and a reminder to refer survivors to the long‐term survivor clinic (LTSC) 2 years after ...
Ji Yun Tark, Kayla L. Foster, Omar Shakeel, Mary C. Shapiro, Shawki L. Qasim, ZoAnn Dreyer, Eric S. Schafer, Ashley M. Butler, Austin L. Brown, Maria Monica Gramatges   +9 more
wiley   +1 more source